CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18337493.
- Also identified by DOI 10.1073/pnas.0709118105 and PMC identifier 2393814.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Congenital long- or short-QT syndrome may lead to life-threatening ventricular tachycardia and sudden cardiac death. Apart from the rare disease-causing mutations, common genetic variants in CAPON, a neuronal nitric oxide synthase (NOS1) regulator, have recently been associated with QT interval variations in a human whole-genome association study. CAPON had been unsuspected of playing a role in cardiac repolarization; indeed, its physiological role in the heart (if any) is unknown. To define the biological effects of CAPON in the heart, we investigated endogenous CAPON protein expression and protein-protein interactions in the heart and performed electrophysiological studies in isolated ventricular myocytes with and without CAPON overexpression. We find that CAPON protein is expressed in the heart and interacts with NOS1 to accelerate cardiac repolarization by inhibition of L-type calcium channel. Our findings provide a rationale for the association of CAPON gene variants with extremes of the QT interval in human populations.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Cell Polarity
- Myocardium
- Nitric Oxide Synthase Type I
- Signal Transduction